NUR 550 - TRANSLATIONAL RESEARCH AND POPULATION HEALTH MANAGEMENT COMPLETE FINAL EXAM QUESTIONS AND CORRECT ANSWERS 2026/2027

NUR-550 - TRANSLATIONAL RESEARCH AND POPULATION HEALTH
MANAGEMENT COMPLETE FINAL EXAM QUESTIONS AND CORRECT
ANSWERS 2026/2027




NUR-550 - Translational Research and Population Health Management


Q: What is translational research? ANSWER It is the process of applying
discoveries generated in the laboratory or preclinical studies to the
development of clinical trials and ultimately to clinical practice and
population health.
Q: What are the four phases (T1-T4) of translational research? ANSWER
T1 (Basic to Clinical), T2 (Clinical to Practice), T3 (Practice to
Community), T4 (Community to Policy).
Q: Describe the T1 phase of translational research. ANSWER It involves
translating basic laboratory discoveries into human studies, including
phase I and II clinical trials.
Q: Describe the T2 phase of translational research. ANSWER It focuses
on translating clinical findings to clinical practice, guidelines, and
evidence-based interventions (phase III trials).
Q: Describe the T3 phase of translational research. ANSWER It involves
moving evidence-based practices into community settings and real-world
health delivery systems.
Q: Describe the T4 phase of translational research. ANSWER It focuses
on translating population health data and outcomes to impact health
policy and global health.
Q: How does translational research differ from basic research? ANSWER
Basic research seeks to generate new knowledge without immediate
practical application, while translational research specifically aims to
apply knowledge to improve human health.

,Q: How does translational research differ from applied research?
ANSWER Applied research solves practical problems, but translational
research is specifically a multi-step continuum bridging the gap between
bench (lab) and bedside (clinic/community).
Q: What is the "valley of death" in translational research? ANSWER It
refers to the gap between basic science discoveries and their successful
application in clinical practice due to lack of funding or infrastructure.
Q: What is implementation science? ANSWER It is the scientific study of
methods to promote the adoption and integration of evidence-based
practices into routine clinical care.
Q: How does implementation science relate to T3 translation? ANSWER
Implementation science provides the frameworks and methodologies used
to execute T3 translation effectively.
Q: What is the primary goal of NUR-550 from a translational perspective?
ANSWER To prepare nurses to lead and participate in the translation of
evidence into practice to improve population health outcomes.
Q: What role does a DNP-prepared nurse play in translational research?
ANSWER They evaluate and translate evidence into practice, lead practice
changes, and evaluate patient/population outcomes.
Q: What role does a PhD-prepared nurse play in translational research?
ANSWER They typically generate new knowledge and conduct the
primary research (often T1/T2) that is later translated.
Q: What is a knowledge gap in the context of translational research?
ANSWER A lack of understanding or evidence regarding a specific health
issue, intervention, or process.
Q: What is a practice gap? ANSWER The difference between current
clinical practice and evidence-based best practices.
Q: What is a translational gap? ANSWER The delay or failure in moving a
proven intervention from one phase of translation to the next.
Q: Why is team science important in translational research? ANSWER
Complex health problems require interdisciplinary collaboration (e.g.,
clinicians, scientists, statisticians, community members) to successfully
translate evidence.

, Q: What is the Clinical and Translational Science Awards (CTSA) program?
ANSWER A program funded by the NIH designed to accelerate clinical
and translational research across the US.
Q: Define "bench-to-bedside." ANSWER A phrase describing the T1
translation of basic laboratory (bench) discoveries to clinical applications
at the patient's bedside.
Q: Define "bedside-to-community." ANSWER A phrase describing the T3
translation of proven clinical practices into broader community and public
health settings.
Q: What is precision medicine? ANSWER An approach to healthcare that
tailors disease prevention and treatment based on an individual’s
genetics, environment, and lifestyle.
Q: How does precision medicine impact translational research? ANSWER
It accelerates the T1 and T2 phases by utilizing genomic data to create
targeted therapies.
Q: What is comparative effectiveness research (CER)? ANSWER Research
that compares the benefits and harms of alternative clinical interventions
in real-world settings.
Q: In which translational phase does CER primarily operate? ANSWER T2
and T3.
Q: What is health services research (HSR)? ANSWER Research that
examines how people get access to health care, how much care costs, and
what happens to patients as a result of this care.
Q: How does HSR support population health management? ANSWER It
identifies systemic inefficiencies and evaluates policies to improve the
delivery of care to populations.
Q: What is a learning health system (LHS)? ANSWER A health system in
which science, informatics, incentives, and culture are aligned to
continuously improve care and generate new knowledge.
Q: How does an LHS rely on translational research? ANSWER It
inherently integrates T2, T3, and T4 by constantly cycling data from
practice back into research and policy.
Q: What is community-based participatory research (CBPR)? ANSWER A
collaborative approach that equitably involves community members,